Thermo Fisher Scientific (TMO) Land & Improvements (2009 - 2010)
Thermo Fisher Scientific's (TMO) quarterly Land & Improvements came in at $144.3 million in Q4 2010, down 1.3% on a YoY basis from $146.2 million in Q4 2009, and down 1.3% quarter-over-quarter from $146.2 million in Q4 2009.
Analysis
Thermo Fisher Scientific (TMO) Land & Improvements (2009 - 2010) Analysis & Trends
Thermo Fisher Scientific (TMO) has reported Land & Improvements for 2 consecutive years, with $144.3 million the latest figure, recorded in Q4 2010.
- For the quarter ending Q4 2010, Land & Improvements fell 1.3% year-over-year to $144.3 million; the trailing twelve-month figure through Dec 2010 stood at $144.3 million (down 1.3% YoY), and the FY2010 full-year result was $144.3 million, down 1.3% from the prior year.
- Land & Improvements fell to $144.3 million in Q4 2010 per TMO's latest filing, from $146.2 million in the prior quarter.
- Across five years, Land & Improvements topped out at $146.2 million in Q4 2009 and bottomed at $144.3 million in Q4 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | - |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | - |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | - |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | - |